Dr. Roland Andersson, is Senior Vice President, Clinical Research Services.  Within CRS, he manages and develops PAREXEL’s client relationships, including strategic accounts and key accounts. Dr. Andersson has extensive experience leading and transforming businesses within the biotechnology, pharmaceutical and medical device sectors, with primary expertise in Research and Development (R&D) management, transformation, strategy, and business development.  Prior to joining PAREXEL, he was Managing Director at Accenture, where he oversaw technology, consulting and business services for leading pharmaceutical and biotech companies.  While at Accenture, he played a pivotal role in the creation of the industry group TransCelerate, which aligns 18 of the world’s best-known biopharmaceutical companies to address common drug development problems.  Dr. Roland Andersson, is Senior Vice President, Clinical Research Services.  Within CRS, he manages and develops PAREXEL’s client relationships, including strategic accounts and key accounts. Dr. Andersson has extensive experience leading and transforming businesses within the biotechnology, pharmaceutical and medical device sectors, with primary expertise in Research and Development (R&D) management, transformation, strategy, and business development.  Prior to joining PAREXEL, he was Managing Director at Accenture, where he oversaw technology, consulting and business services for leading pharmaceutical and biotech companies.  While at Accenture, he played a pivotal role in the creation of the industry group TransCelerate, which aligns 18 of the world’s best-known biopharmaceutical companies to address common drug development problems. 

Dr. Roland Andersson is expertise in leading trasforming business within the biotechnology,Research and Development (R&D) management, transformation, strategy, and business development.